1.Arvin, AM. Varicella-zoster virus. Clinical Microbiology Reviews 1996; 9: 361–381.
2.Davis, MM, Patel, MS, Gebremariam, A. Decline in varicella-related hospitalization and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics 2004; 114: 786–792.
3.Nguyen, HQ, Jumaan, AO, Seward, JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. New England Journal of Medicine 2005; 352: 450–458.
4.Bonanni, P, et al. Varicella vaccination in Europe – taking the practical approach. BMC Medicine 2009; 7: 26.
5.Kilgore, P, et al. Varicella in Americans from NHANES III: implications for control through routine immunization. Journal of Medical Virology 2003; 70 (Suppl. 1): S111–118.
6.Marin, M, Meissner, HC, Seward, JF. Varicella prevention in the United States: areview of successes and challenges. Pediatrics 2008; 122: e744–e751.
7.Watson, B. Varicella: a vaccine preventable disease? Journal of Infection 2002; 44: 220–225.
8.Seward, J, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995–2000. Journal of the American Medical Association 2002; 287: 606–611.
9.Edmunds, WJ, Brisson, M. The effect of vaccination on the epidemiology of varaicella zoster virus. Journal of Infection 2002; 44: 211–219.
10.Levin, M, et al. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. Journal of Infectious Diseases 2003; 188: 1336–1344.
11.Thomas, SL, Wheeler, JG, Hall, AJ. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet 2002; 360: 678–682.
12.Gao, Z, et al. Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia. Epidemiology and Infection 2010; 138: 457–468.
13.Karhunen, M, et al. Modelling the impact of varicella vaccination on varicella and zoster. Epidemiology and Infection 2010; 138: 469–481.
14.Hambleton, S, et al. Risk of herpes zoster in adults immunized with varicella vaccine. Journal of Infectious Diseases 2008; 197: S196–199.
15.Goldman, GS. Universal varicella vaccination: efficacy trends and effect on herpes zoster. International Journal of Toxicology 2005; 24: 205–213.
16.Jumaan, AO, et al. Incidence of herpes zoster, before and after varicella-vaccination–associated decreases in the incidence of varicella, 1992–2002. Journal of Infectious Diseases 2005; 191: 2002–2007.
17.Thomas, SL, Hall, AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infectious Diseases 2004; 4: 26–33.
18.Lin, Y-H, et al. Disease burden and epidemiological characteristics of varicella in Taiwan from 2000 to 2005. Journal of Microbiology, Immunology and Infection 2009; 42: 5–12.
19.Tan, H-F, et al. The incidence of varicella in southern Taiwan: a life table method estimation among susceptible population. Vaccine 2004; 22: 2730–2736.
20.Tseng, H-F, Tan, H-F, Chang, C-K. Use of national health insurance database to evaluate the impact of public varicella vaccination program on burden of varicella in Taiwan. Vaccine 2006; 24: 5341–5348.
21.Lian, I-B, et al. The changing epidemiology of varicella incidence after implementation of the one-dose varicella vaccination policy. Vaccine 2011; 29: 1448–1454.
22.Tan, H-F, et al. Evaluation of the National Notifiable Disease Surveillance System in Taiwan: an example of varicella reporting. Vaccine 2007; 25: 2630–2633.
23.Wen, CP, Tsai, SP, Chung, W-SI. A 10-year experience with universal health insurance in Taiwan: measuring changes in health and health disparity. Annals of Internal Medicine 2008; 148: 258–267.
24.Chen, L, et al. The effects of Taiwan's national health insurance on access and health status of the elderly. Health Economics 2007; 16: 223–242.
25.Pinot de Moira, A, Nardone, A, ESEN2 group. Varicella zoster virus vaccination policies and surveillance strategies in Europe. Eurosurveillance 2005; 10: 43–45.
26.Lin, Y-H, et al. Disease burden and epidemiology and herpes zoster in pre-vaccine Taiwan. Vaccine 2010; 28: 1217–1220.
27.Donahue, J, et al. Herpes zoster and exposure to the varicella zoster virus in an era of varicella vaccination. American Journal of Public Health 2010; 100: 1116–1122.
28.Steina, AN, et al. Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older. Vaccine 2009; 27: 520–529.
29.Brisson, M, Edmunds, WJ. Epidemiology of varicella-zoster virus in England and Wales. Journal of Medical Virology 2003; 70: S9–S14.
30.Melker, Hd, et al. The epidemiology of varicella and herpes zoster in the Netherlands: implications for varicella zoster virus vaccination. Vaccine 2006; 24: 3946–3952.
31.Coplan, P, Black, S, Rojas, C. Incidence and hospitalization rates of varicella and herpes zoster before varicella vaccine introduction: a baseline assessment of the shifting epidmiology of varicella disease. Pediatric Infectious Disease Journal 2001; 20: 641–645.
32.Carville, KS, Riddell, MA, Kelly, HA. A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia. Vaccine 2010; 28: 2532–2538.
33.Jardine, A, Conaty, SJ, Vally, H. Herpes zoster in Australia: evidence of increase in incidence in adults attributable to varicella immunization? Epidemiology and Infection 2011; 139: 658–665.
34.Nardone, A, et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 2007; 25: 7866–7872.
35.Brisson, M, et al. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine 2002; 20: 2500–2507.
36.Garnett, GP, Grenfell, BT. The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster. Epidemiology and Infection 1992; 108: 513–528.
37.Garnett, GP, Grenfell, BT. The epidemiology of varicella-zoster virus infections: a mathematical model. Epidemiology and Infection 1992; 108: 495–511.
38.Goldman, GS. Incidence of herpes zoster among children and adolescents in a community with moderate varicella vaccination coverage. Vaccine 2003; 21: 4243–4249.
39.Edmunds, WJ, Brisson, M. The effect of vaccination on the epidemiology of varicella zoster virus. Journal of Infection 2002; 44: 211–219.
40.Jackson, LA, Reynolds, MA, Harpaz, R. Hospitalizations to treat herpes zoster in older adults: causes and validated rates. Clinical Infectious Diseases 2008; 47: 754–759.